GlassScriptPhysician profile
Dean Mundhenke
NPI 1447356092
$416.86
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $56.62 · 2021: $154 · 2022: $57.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $87.54 | 2021-2022 | |
| Pfizer INC. | $46.43 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $41.25 | 2019 | |
| Amarin Pharma, INC. | $38.39 | 2020-2021 | |
| Glaxosmithkline, LLC. | $28.44 | 2022 | |
| Sanofi Pasteur INC. | $26.94 | 2019 | |
| Novo Nordisk INC | $24.27 | 2019-2020 | |
| Hologic Sales and Service, LLC | $16.62 | 2019 | |
| Mylan Specialty L.P. | $16.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.52 | 2021 | |
| Medtronic, INC. | $13.30 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $12.34 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.32 | 2019 | |
| Amgen INC. | $12.12 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Mundhenke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.